Literature DB >> 15888703

The fate of circulating osteoblasts.

Ernesto Canalis.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15888703     DOI： 10.1056/NEJMe058080

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  28 in total

Review 1.  Update in new anabolic therapies for osteoporosis.

Authors:  Ernesto Canalis
Journal:  J Clin Endocrinol Metab       Date:  2010-04       Impact factor: 5.958

2.  IGF-1 Signaling is Essential for Differentiation of Mesenchymal Stem Cells for Peak Bone Mass.

Authors:  Janet L Crane; Luo Zhao; Joseph S Frye; Lingling Xian; Tao Qiu; Xu Cao
Journal:  Bone Res       Date:  2013-06-28       Impact factor: 13.567

Review 3.  Notch regulation of bone development and remodeling and related skeletal disorders.

Authors:  Stefano Zanotti; Ernesto Canalis
Journal:  Calcif Tissue Int       Date:  2011-10-16       Impact factor: 4.333

Review 4.  New treatment modalities in osteoporosis.

Authors:  Ernesto Canalis
Journal:  Endocr Pract       Date:  2010 Sep-Oct       Impact factor: 3.443

Review 5.  Biomechanics and mechanobiology of trabecular bone: a review.

Authors:  Ramin Oftadeh; Miguel Perez-Viloria; Juan C Villa-Camacho; Ashkan Vaziri; Ara Nazarian
Journal:  J Biomech Eng       Date:  2015-01       Impact factor: 2.097

Review 6.  Notch Signaling in Osteogenesis, Osteoclastogenesis, and Angiogenesis.

Authors:  Zhengliang Luo; Xifu Shang; Hao Zhang; Guangxi Wang; Patrick A Massey; Shane R Barton; Christopher G Kevil; Yufeng Dong
Journal:  Am J Pathol       Date:  2019-08       Impact factor: 4.307

Review 7.  Hajdu-Cheney Syndrome, a Disease Associated with NOTCH2 Mutations.

Authors:  Ernesto Canalis; Stefano Zanotti
Journal:  Curr Osteoporos Rep       Date:  2016-08       Impact factor: 5.096

8.  Notch1 and Notch2 expression in osteoblast precursors regulates femoral microarchitecture.

Authors:  Stefano Zanotti; Ernesto Canalis
Journal:  Bone       Date:  2014-02-04       Impact factor: 4.398

Review 9.  MANAGEMENT OF ENDOCRINE DISEASE: Novel anabolic treatments for osteoporosis.

Authors:  Ernesto Canalis
Journal:  Eur J Endocrinol       Date:  2017-11-07       Impact factor: 6.664

Review 10.  Growth factor control of bone mass.

Authors:  Ernesto Canalis
Journal:  J Cell Biochem       Date:  2009-11-01       Impact factor: 4.429
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.